Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death - PubMed (original) (raw)

Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death

I Rodriguez et al. J Exp Med. 1996.

Abstract

Mice injected with anti-Fas antibody die within a few hours with total liver destruction due to massive apoptosis of hepatocytes. We show that this is preceded and accompanied by the sequential activation of cysteine proteases of the interleukin 1 beta-converting enzyme (ICE) and CPP32 types in the cytosol of the hepatocytes, and that proCPP32 cleavage and enzymatic activity can be prevented by intravenous injections of the tripeptide N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD.fmk), an inhibitor of ICE-like proteases. Four Z-VAD.fmk injections at 1-hour intervals abolished all signs of liver damage after anti-Fas antibody injection and resulted in 100% long-range recovery, without residual tissue damage, from a condition otherwise uniformly fatal within < 3 hours. This treatment was effective even when delayed until some liver DNA degradation was already detectable. Injections of the tetrapeptide Ac-YVAD.cmk, more specific for the ICE-like subfamily of cysteine proteases but less cell permeable, also gave protection, but at higher doses and when injections started before that of anti-Fas antibody. These observations afford a way of temporarily modulating a number of apoptotic processes in vivo and may have important therapeutic implications in some human diseases.

PubMed Disclaimer

Cited by

Role of Pyroptosis in Acetaminophen-Induced Hepatotoxicity.
Jaeschke H, Umbaugh DS, Ramachandran A. Jaeschke H, et al. Livers. 2022 Dec;2(4):425-435. doi: 10.3390/livers2040032. Epub 2022 Dec 13. Livers. 2022. PMID: 36588962 Free PMC article.
Intestinal differentiation involves cleavage of histone H3 N-terminal tails by multiple proteases.
Ferrari KJ, Amato S, Noberini R, Toscani C, Fernández-Pérez D, Rossi A, Conforti P, Zanotti M, Bonaldi T, Tamburri S, Pasini D. Ferrari KJ, et al. Nucleic Acids Res. 2021 Jan 25;49(2):791-804. doi: 10.1093/nar/gkaa1228. Nucleic Acids Res. 2021. PMID: 33398338 Free PMC article.
Peptidyl Fluoromethyl Ketones and Their Applications in Medicinal Chemistry.
Citarella A, Micale N. Citarella A, et al. Molecules. 2020 Sep 3;25(17):4031. doi: 10.3390/molecules25174031. Molecules. 2020. PMID: 32899354 Free PMC article. Review.
Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure.
Al-Saeedi M, Steinebrunner N, Kudsi H, Halama N, Mogler C, Büchler MW, Krammer PH, Schemmer P, Müller M. Al-Saeedi M, et al. Cell Death Dis. 2018 Jan 26;9(2):132. doi: 10.1038/s41419-017-0150-0. Cell Death Dis. 2018. PMID: 29374146 Free PMC article.
Caspase inhibitors for the treatment of liver disease: friend or foe?
Woolbright BL, Ding WX, Jaeschke H. Woolbright BL, et al. Expert Rev Gastroenterol Hepatol. 2017 May;11(5):397-399. doi: 10.1080/17474124.2017.1300060. Epub 2017 Mar 4. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28276808 Free PMC article. No abstract available.

References

1. Cell. 1996 Jun 14;85(6):817-27 - PubMed
1. Cell. 1996 Jun 14;85(6):803-15 - PubMed
1. Curr Biol. 1996 May 1;6(5):555-62 - PubMed
1. Nat Biotechnol. 1996 Mar;14(3):297-301 - PubMed
1. Cell. 1989 Sep 8;58(5):923-31 - PubMed

Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death - PubMed (original) (raw)